Comparison
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858 vs 15q14 Microdeletion Syndrome C4305230
Clinical comparison between 21 Hydroxylase Deficient Congenital Adrenal Hyperplasia and 15q14 Microdeletion Syndrome for differential diagnosis and treatment planning.
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858
An inherited disorder affecting adrenal hormone production, causing cortisol deficiency and other hormonal imbalances. Features may include ambiguous genitalia, salt-wasting crises, and growth issues. Treated with lifelong hormone replacement therapy.
15q14 Microdeletion Syndrome C4305230
A rare chromosomal condition where a small piece of chromosome 15 is missing. It can be associated with congenital heart defects, developmental delays, and distinctive facial features. Care focuses on addressing specific health and developmental needs.
6 comparison axes
Onset
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858
0-null
15q14 Microdeletion Syndrome C4305230
0-null
Onset patterns differ
Severity
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858
severe
15q14 Microdeletion Syndrome C4305230
moderate
Different severity levels
Chronic
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858
Chronic
15q14 Microdeletion Syndrome C4305230
Chronic
Differing course
Communicable
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858
No
15q14 Microdeletion Syndrome C4305230
No
Different transmission
Body System
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858
endocrine
15q14 Microdeletion Syndrome C4305230
congenital
Same/different system
Category
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858
endocrine
15q14 Microdeletion Syndrome C4305230
genetic
Different category
Bottom line
21-hydroxylase-deficient-congenital-adrenal-hyperplasia-C2936858 and 15q14-microdeletion-syndrome-C4305230 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858 | 15q14 Microdeletion Syndrome C4305230 | Discriminating power |
|---|---|---|---|
| Hormone imbalance | Cortisol deficiency and other adrenal hormone imbalance may occur. | Not described as a primary adrenal hormone disorder. | High |
| Genital or growth features | Ambiguous genitalia and growth issues may occur. | Distinctive facial features may occur; genital findings are not established. | Moderate |
| Heart and development | Not described as a chromosomal heart-defect syndrome. | Congenital heart defects and developmental delay may be associated. | Moderate |
When to favor each condition
Choose 21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858 when
Possible salt-wasting crisis
The source links this condition to cortisol deficiency and salt-wasting crises.
High
Ambiguous genitalia with endocrine concern
Atypical genitalia are a described possible feature.
Moderate
Planning hormone replacement
The source states treatment involves lifelong hormone replacement.
High
Choose 15q14 Microdeletion Syndrome C4305230 when
15q14 deletion identified
The condition is defined by missing material from chromosome 15.
High
Heart defect with developmental delay
These associations are described, but do not alone confirm the syndrome.
Moderate
Need for supportive developmental care
Care focuses on the person’s specific health and developmental needs.
Moderate
How key tests differ
| Test | 21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858 | 15q14 Microdeletion Syndrome C4305230 | Interpretation |
|---|---|---|---|
| Adrenal steroid profile | May be abnormal; no cutoff is supplied. | Not the defining test in the source. | An abnormal result is not itself a diagnosis and needs clinician review. |
| Serum electrolytes | May change during salt wasting; thresholds are not supplied. | No characteristic electrolyte pattern is established. | Results require clinical context and do not distinguish the conditions alone. |
| Chromosomal microarray | 15q14 deletion is not the described basis. | May show a small missing segment at 15q14. | Genetic findings need correlation with clinical features. |
Prognosis comparison
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858
- Outcome
- Chronic endocrine condition; exact survival is not established here.
- Factors
- Recognition of crises, hormone management, growth, and individual severity.
15q14 Microdeletion Syndrome C4305230
- Outcome
- Chronic congenital condition with variable course; prognosis is not quantified.
- Factors
- Heart findings, developmental needs, and available supportive care.
Time frame: Both are described as chronic or lifelong; precise timelines are unavailable.
Early recognition, specialist care, and associated complications influence course.
Complications comparison
| Complication | Presentation |
|---|---|
| Salt-wasting crisis | A possible acute complication. Not established from the supplied description. Urgent clinician assessment is needed for suspected adrenal crisis. |
| Congenital heart defect | Not described as a typical feature. May be associated. Cardiac findings require specialist evaluation. |
| Growth or developmental difficulty | Growth issues may occur. Developmental delay may occur. The pattern and severity vary and are not quantified here. |
Patient education highlights
- HighUrgent symptoms
Seek urgent care for suspected salt-wasting or adrenal crisis; this warning applies mainly to the adrenal condition.
- MediumDifferent causes
One is an inherited adrenal disorder; the other is a chromosomal microdeletion. Neither is described as communicable.
- MediumIndividual follow-up
Monitoring, hormone treatment, cardiac care, and developmental support depend on confirmed findings.